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Abstract 
We wish to report a simple procedure for the preparation of 5-substituted-thienopyridin-7-ones 
and 7-substituted-1,6-naphthyridin-5(6H)-ones, in good yields, from the dianions of 3-
methylthiophene-2-carboxylic and 2-methylnicotinic acids on treatment with nitriles. 
 






Development of new approaches to the 2-pyridone ring is a topical area of continuous interest 
due to the high number of biologically active molecules containing this moiety 1 and to the facile 
conversion of pyridones to the corresponding pyridines. 2 Tautomerism between 2-pyridones and 
2-hydroxypyridines receives constant attention because these compounds may act as simple 
models for investigating the mechanisms of some enzymatic reactions or for discerning the 
behaviour of nucleic acids bases in connection with mutation due to base mispairing. 3 Recent 
studies have shown the usefulness of 2-pyridones as intermolecular connectors between building 
blocks in material science. 4 Thus, despite the large number of methods known for their 
synthesis, 5 new procedures are continuously being developed. 6 
Reactions of aryl amide enolates with nitriles to afford 2-isoquinolines are known, 7 but our 
studies on the reactivity of dienediolates from unsaturated carboxylic acids had led us to a 
simpler synthesis of 4,6-disubstituted- and 3,4,6-trisubstituted-2-pyridones from easily accessible 
carboxylic acids and nitriles. 8 On work-up, pure pyridone was isolated from the neutral fraction 
whereas the starting acid was recovered from the acidic fraction. The method has been readily 
reproduced showing it to be reliable. 9 We found it interesting to study its extension to the 
synthesis of condensed heteroaromatic systems, both by introduction of heterocyclic nitriles and 
by using the well known o-toluic (2), 3-methyl-2-thiophenecarboxylic (3) and 2-methylnicotinic 
(4) acids that, after double deprotonation afford the corresponding lithium dianions. The 
synthetic interest of the dianion from o-toluic acid (2) has been amply demonstrated 10 but, 
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surprisingly, the dianions from 3-methyl-2-thiophenecarboxylic (3) and 2-methylnicotinic (4) 



































b) R = CH(CH3)2

















Results and Discussion 
 
The results obtained on reaction of these dianions and nitriles (Scheme 1) are summarized in 
Table 1. 
Although reaction conditions are not critical to obtain the corresponding pyridones, yields are 
variable and optimisation for each acid and nitrile was performed, specially those leading to 5-
substituted-thienopyridin-7(6H)-ones (7) and 7-substituted-1,6-naphthyridin-5(6H)-ones (8) as 
they render information about the generation and behaviour of 3-methyl-2-thiophenecarboxylic 
(3) and 2-methylnicotinic (4) dianions. Room temperature, 24 hours of reaction time and 1:1 
ratio of acid and nitrile was always the best choice. On the other hand, the nature and amount of 
the amine used for acid deprotonation determines the reaction yield. In most cases, dienediolates 
of unsaturated carboxylic acids can be generated, without Barbier’s reduction or Michael adduct 
formation, by deprotonation of the corresponding acid with butyllithium in the presence of a 
catalytic amount of amine. 12 This renders dienediolates compatible with a large number of 
functional groups, as it happens with nitriles where self-condensation is minimized under these 
conditions. Unfortunately, this cannot be considered a general rule (see entries 6 to 9 in Table 1) 
and it is convenient to optimise the amine and its amount for each acid and nitrile, as used to 
happen in similar reactions. 7 
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2-Pyridinecarbonitrile (e) is specially prone to give self-condensation under the basic 
conditions used, leading to complicated reaction mixtures until the right conditions, usually 
catalytic amount of amine, were found. In some cases (entry 12) only pure trimerization product, 
2,4,6-tri(2-pyridyl)-1,3,5-triazine (9), could be obtained in a good yield (Figure 1). 
 
Table 1. Nucleophilic addition to nitriles 
Entry Acid Nitrile BuLi (2eq) + 





1 1 e Et2NH (2) 4 5e (40) 
2 1 e i-Pr2NH (0.4) 51 5e (22) 
3 2 e Et2NH (2) 70a  
4 2 e i-Pr2NH (0.4) 30 6e (62) 
5 3 a i-Pr2NH (0.4) 25 7a (56) 
6 3 b Et2NH (2) 71 7b (25) 
7 3 b Et2NH (0.4) 82 7b (16) 
8 3 b i-Pr2NH (2) 47 7b (41) 
9 3 b i-Pr2NH (0.4) 34 7b (62) 
10 3 c i-Pr2NH (0.4) 40 7c (55) 
11 3 d i-Pr2NH (0.4) 33 7d (62) 
12 3 e i-Pr2NH (0.4) 65b  
13 4 a Et2NH (2) 7 8a (35) 
14 4 a Et2NH (0.4) 5 8a (32) 
15 4 b Et2NH (2) 6 8b (50) 
16 4 b Et2NH (0.4) 5 8b (21) 
17 4 b i-Pr2NH (0.4) 10 8b (25) 
18 4 c Et2NH (2)  8c (42) 
19 4 c Et2NH (0.4) 9 8c (61) 
20 4 d Et2NH (2) 8 8d (75) 
21 4 d Et2NH (0.4) 4 8d (64) 
22 4 d i-Pr2NH (0.4)  8d (0) 
23 4 e i-Pr2NH (0.4)  8e (56) 
a.- 47% polymeric material; b.- 46% 2,4,6-tri(pyridyl)-1,3,5-triazine (9). 
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Tautomerism 
Both amidic and phenolic tautomeric forms of compound 6e precipitate from water in a 2:1 ratio. 
By treatment with chloroform, both tautomers can be easily isolated. The first is soluble in 
chloroform and the second is highly insoluble. Their spectroscopic data are consistent with the 
proposed structures for both tautomers and provide us with a model that allows us to establish the 





In conclusion it can be said that o-methylarenic acids may be converted, under suitable 
conditions, into the corresponding dianions which show similar nucleophilic behaviour to the 
dienediolates of unsaturated carboxylic acids. It has been shown that condensed heteroaromatic 
systems are obtained from these dianions and nitriles through a tandem addition-cyclization 





General Procedures. M.p.s. were determined with a Reichert apparatus and are uncorrected. IR 
spectral data were obtained as liquid films or KBr discs using a Perkin-Elmer 281 
spectrophotometer. NMR spectra were recorded in CDCl3 or deuterated DMSO solutions, using 
a Varian Unity 300 or Unity 400 spectrometer. A series of COSY, NOESY and HMQC nmr 
experiments were carried out to assign both 1H and 13C signals. Elemental analyses were 
determined by “Servicio de Semimicroanálisis del Centro de Investigación y Desarrollo (CSIC) 
de Barcelona”. High resolution mass spectra were determined with a UG Autoespec 
spectrometer. Silica gel Merck 60 (230-400 mesh) was used for flash column chromatography, 
with hexane/diethyl ether mixtures for elution. 
All reactions were carried out under argon atmosphere, using standard conditions for exclusion 
of moisture, in oven dried glassware, in THF freshly distilled from blue benzophenone ketyl and 
with diethyl amine and diisopropylamine distilled from CaH2. The reaction temperature (-78oC) 
was achieved by cooling with a CO2/acetone bath. Organic extracts were dried over anhyd 
MgSO4, and solutions were evaporated under reduced pressure with a rotary evaporator and a 
bath at 40oC. 
 
General procedure for the synthesis of 2-pyridones 
Carboxylic acid (2.25 mmol) in THF (2 ml) was slowly added to a stirred mixture of n-
butyllithium and dialkylamine (see Table 1) in THF (2 ml) at -78ºC, according to the method 
already described. The solution was stirred for 60 min at 0ºC and cooled again at -78ºC. Nitrile 
(2.25 mmol) in THF (2 ml) was added dropwise, and the solution stirred at room temperature for 
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24 hours. Water (20 ml) was added and the product isolated by crystallization from crude in most 
cases, leading to pure products. In other cases, water was added, extracted with dichloromethane 
(3x15ml) and the combined organic layers were washed with brine to neutral pH, and dried. 
Evaporation of the solvent gave crude 2-pyridone product. The aqueous layer was acidified 
under ice-cooling bath by careful addition of conc. hydrochloric acid and then extracted with 
ethyl acetate (3x 15 ml). The acidic organic layer was washed with brine, dried and evaporation 
of the solvent gave the recovered starting acid. 
4-Methyl-6-(2-pyridinyl)pyridin-2(1H)-one (5e). From 3-methyl-2-butenoic acid 1 (226 mg, 
2.25 mmol) and 2-cyanopyridine e (235 mg, 2.25 mmol) and lithium diethylamide (from BuLi 
3.2 ml, 1.6 molar, and diethylamine 0.5 ml, 5 mmol).Yield: 168 mg (40%); m.p. 84-85oC (yellow 
prism). Recovered starting acid: 9 mg (4%). 
IR (KBr): νmax= 3400, 3100-2800, 1655, 1614, 1580, 1481, 854 cm-1. 
1H NMR (MeOD, 300MHz): δ= 8.63 (d, 1H, J=4.8 Hz, N-CH), 7.92 (d, 1H, J=8.1 Hz, N-C-
CH), 7.84 (dt, 1H, J=8.1 and 1.5 Hz, N-CH-CH-CH-CH), 7.38 (ddd, 1H, J=8.1, 4.8 and 1.5 Hz, 
N-CH-CH-CH-CH), 6.92 (d, 1H, J=1.5 Hz, CH-CONH), 6.35 (d, 1H, J=1.5 Hz, CH-C-NH), 
2.26 (s, 3H, CH3) 
13C NMR (MeOD, 75MHz) δ= 164.1 (C=O), 154.7 (C-CH3), 149.3 (N-CH), 148.1 (C-NHCO), 
141.6 (C-N), 137.8 (N-CH-CH-CH-CH), 124.9 (N-CH-CH-CH-CH), 120.5 (N-C-CH), 118.6 
(CH-CONH), 107.4 (CH-C-NHCO), 20.6 (CH3). 
MS (EI): m/z (%) = 186 (M+, 100), 158 (M+-CO, 41), 157 (M+-COH, 56), 79 (C5H5N+, 10), 78 
(C5H4N+, 8) 
HRMS: m/z calcd for C11H10N2O (M+) 186.0793, found: 186.0792. 
3-(2-Pyridinyl)isoquinolin-1(2H)-one (6e). From o-toluic acid 2 (306 mg, 2.25 mmol) and 2-
cyanopyridine e (237 mg, 2.25 mmol) and lithium diisopropylamide (from BuLi 3.2 ml, 1.6 
molar, and isopropylamine 0.14 ml, 0.96 mmol).Yield: 310 mg (62%). Recovered starting acid: 
92 mg (30%). 
The fraction soluble in CHCl3 was identified as the above isoquinolone, m.p. 136-137oC (yellow 
solid). IR (KBr): νmax= 3329, 3200-2900, 1659, 1470, 1437, 1342, 1146, 855, 788, 730 cm-1. 1H 
NMR (CDCl3, 500MHz): δ= 10.44 (brs, 1H, NH), 8.66 (d, 1H, J=4.1 Hz, CH-N), 8.47 (d, 1H, 
J=8.0 Hz, CH-C=C-CONH), 7.94 (d, 1H, J=7.5 Hz, N-C-CH), 7.82 (dt, 1H, J=7.5 and 1.5 Hz, 
N-CH-CH-CH-CH), 7.69 (dt, 1H, J=8.0 and 1.3 Hz, CH-CH-C-CONH), 7.65 (d, 1H, J=8.0 Hz, 
CH-C-CONH), 7.53 (dt, 1H, J=8.0 and 1.3 Hz, CH-CH-C-C-CONH), 7.35 (ddd, 1H, J=7.5, 4.1 
and 1.5 Hz, N-CH-CH-CH-CH), 7.16 (s, 1H, CH-C-NH). 13C NMR (MeOD, 75MHz) δ= 162.3 
(C=O), 149.0 (N-CH), 148.8 (C-NHCO), 137.7 (C-N), 137.1 (N-CH-CH-CH-CH), 135.7 (C-C-
CONH), 132.6 (CH-CH-C-CONH), 127.8 (CH-C-C-CONH), 127.4 (CH-CH-C-C-CONH), 
126.9 (CH-C-CONH), 124.8 (C-CONH), 123.9 (N-CH-CH-CH-CH), 119.2 (N-C-CH), 103.4 
(CH-C-NHCO). MS (EI): m/z (%) = 223 (M++1, 18), 222 (M+, 100), 194 (M+-CO, 14), 193 (M+-
COH, 8), 118 (C8H6O+, 10), 78 (C5H4N+, 5) HRMS: m/z calcd for C11H10N2O (M+) 222.0793, 
found: 222.0796. 
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The fraction soluble in MeOH was identified as the hydroxyisoquinoline, m.p. 180-82oC (dec.) 
(yellow solid). IR (KBr): νmax= 3173, 3050-2900, 1639, 1473, 1435, 1343, 864, 788, 786 cm-1. 
1H NMR (MeOD, 500MHz): δ= 8.64 (d, 1H, J=4.8 Hz, CH-N), 8.29 (d, 1H, J=7.8 Hz, CH-C-C-
CONH), 8.09 (dt, 1H, J=8.0 and 0.9 Hz, N-C-CH), 7.89 (dt, 1H, J=8.0 and 1.8 Hz, N-CH-CH-
CH-CH), 7.74 (m, 2H, CH-CH-C-CONH and CH-C-CONH), 7.52 (ddd, 1H, J=7.8, 6.0 and 2.4 
Hz, CH-CH-C-C-CONH), 7.44 (s, 1H, CH-C-NH), 7.38 (ddd, 1H, J=8.0, 4.8 and 0.9 Hz, N-CH-
CH-CH-CH). 13C NMR (MeOD, 75MHz) δ= 163.6 (COH), 150.5 (C-NHCO), 149.0 (N-CH), 
138.4 (C-N), 137.6 (N-CH-CH-CH-CH), 136.4 (C-C-CONH), 133.1 (CH-CH-C-CONH), 127.5 
(CH-C-C-CONH), 127.4 (CH-CH-C-C-CONH), 126.9 (CH-C-CONH), 125.0 (C-CONH), 124.2 
(N-CH-CH-CH-CH), 120.0 (N-C-CH), 104.8 (CH-C-NHCO). 
5-Ethyl-6,7-dihydrothieno[2,3-c]pyridin-7-one (7a). From 3-methyl-2-thiophenecarboxylic 
acid 3 (326 mg, 2.25 mmol) and propionitrile a (0.16 ml, 2.25 mmol) and lithium 
diisopropylamide (from BuLi 3.2 ml, 1.6 molar, and isopropylamine 0.14 ml, 0.96 mmol).Yield: 
228 mg (56%); m.p. 171-172oC (brown prisms). Recovered starting acid: 82 mg (25%).IR (KBr): 
νmax= 3420, 3100-2800, 1801, 1636, 1525, 1474, 1048, 825 cm-1. 1H NMR (CDCl3, 300MHz): 
δ= 10.58 (s, 1H, NH), 7.70 (d, 1H, J=5.1 Hz, CH=CH-S), 7.18 (d, 1H, J=5.1 Hz, CH=CH-S), 
6.50 (s, 1H, CH-C-NH), 2.70 (q, 2H, J= 7.5 Hz, CH2-CH3), 1.3 (t, 3H, J=7.5 Hz, CH2-CH3). 13C 
NMR (CDCl3, 75MHz) δ= 160.8 (C=O), 147.5 (CH=C-NH), 145.5 (C=C-S), 133.5 (CH=CH-S), 
126.8 (C=C-S), 124.2 (CH=CH-S), 100.7 (CH-C-NH), 26.3 (CH2-CH3), 12.8 (CH3). MS (EI): 
m/z (%) = 179 (M+, 100), 178 (M+-H, 68), 164 (M+-CH3, 38), 160 (M+-H-H2O, 5), 151 (M+-CO, 
12), 137 (M+-CON, 19), 95 (C5H3S+, 5). HRMS: m/z calcd for C9H9NOS (M+) 179.0405, found: 
179.0405. 
5-Isopropyl-6,7-dihydrothieno[2,3-c]pyridin-7-one (7b). From 3-methyl-2-thiophene 
carboxylic acid 3 (326 mg, 2.25 mmol) and isobutyronitrile b (0.20 ml, 2.25 mmol) and lithium 
diisopropylamide (from BuLi 3.2 ml, 1.6 molar, and isopropylamine 0.14 ml, 0.96 mmol).Yield: 
276 mg (62%); m.p. 164-165oC (orange prisms). Recovered starting acid: 117 mg (34%). IR 
(KBr): νmax= 3295; 3142, 1646, 1626 1530,1482, 1087, 1050, 915, 818 cm-1. 1H NMR (CDCl3, 
300MHz): δ= 10.90 (s, 1H, NH), 7.68 (d, 1H, J=5.1 Hz, S-CH=CH), 7.20 (d, 1H, J=5.1 Hz, S-
CH=CH), 6.50 (s, 1H, C-CH-C-NH), 2.95 [m, 1H, C-CH(CH3)2], 1.35 [d, 6H, J=6.3 Hz, C-
CH(CH3)2]. 13C NMR (CDCl3, 75MHz) δ= 160.7 (C=O), 149.7 (C-NH), 147.4 (CH-C=C-S) 
133.4 (CH=CH-S), 127.8 (S-C=C), 124.3 (CH=CH-S), 99.0 (CH=C-NH), 32.1 [CH(CH3)2], 21.8 
[CH(CH3)2]. MS (EI): m/z (%) = 193 (M+, 81), 178 (M+-CH3, 100) 165 (M+-CO, 10) 160 (M+-
CH3-H2O, 19). HRMS: m/z calcd for C10H11NOS (M+) 193.0561, found: 193.0565. 
5-(4-Methylphenyl)-6,7-dihydrothieno[2,3-c]pyridin-7-one (7c) From 3-methyl-2-
thiophenecarboxylic acid 3 (326 mg, 2.25 mmol) and p-methylbenzonitrile c (266 mg, 
2.25 mmol) and lithium diisopropylamide (from BuLi 3.2 ml, 1.6 molar, and isopropylamine 
0.14 ml, 0.96 mmol).Yield: 301 mg (55%); m.p. 252-254oC (yellow solid). Recovered starting 
acid: 131 mg (40%). IR (KBr): νmax= 3100-2900, 1630, 1513, 1474, 1186, 1132, 1045, 808 cm-1. 
1H NMR (CDCl3, 300MHz): δ= 9.38 (s, 1H, NH), 7.73 (d, 1H, J=5.1 Hz, CH=CH-S), 7.58 (d, 
2H, J=8.1 Hz, 2Ar-H), 7.30 (d, 2H, J=8.1 Hz, 2Ar-H), 7.27 (d, 1H, J=5.1 Hz, CH=CH-S), 6.9 
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(s, 1H, CH-C-NH), 2.42 (s, 3H, CH3). 13C NMR (CDCl3, 300MHz) δ= 160.2 (C=O), 147.3 (CH-
C=C-S), 140.1 (CH=C-NH), 134.1 (CH=CH-S), 132.5 (CH3-CAr), 131.5 (C-CAr), 130.2 
(2CHAr), 126.3 (2CHAr), 124.9 (CH=CH-S), 101.3 (CH-C-NH), 21.5 (CH3). MS (EI): m/z (%) 
= 241 (M+,100), 226 (M+-CH3, 4), 119 (M+-C8H7O, 90), 91 (C7H7+, 25). HRMS: m/z calcd for 
C14H11NOS (M+) 241.0561, found 241.0554. 
5-(4-Chlorophenyl)-6,7-dihydrothieno[2,3-c]pyridin-7-one (7d). From 3-methyl-2-
thiophenecarboxylic acid 3 (326 mg, 2.25 mmol) and p-chlorobenzonitrile d (310 mg, 
2.25 mmol) and lithium diisopropylamide (from BuLi 3.2 ml, 1.6 molar, and isopropylamine 
0.14 ml, 0.96 mmol).Yield: 373 mg (62%); m.p. 281-283oC (brown solid). Recovered starting 
acid: 106 mg (33%). IR (KBr): νmax= 3142, 3052, 2913, 1662, 1615, 1499, 1422, 1137, 1090, 
1014, 807 cm-1. 1H NMR (CDCl3, 300MHz): δ= 8.67 (s, 1H, NH), 7.76 (d, 1H, J=5.1 Hz, 
CH=CH-S), 7.62 (d, 2H, J=8.7 Hz, 2Ar-H), 7.48 (d, 2H, J=8.7 Hz, 2Ar-H), 7.28 (d, 1H, 
J=5.1 Hz, CH=CH-S), 6.90 (s, 1H, CH-C-NH). 13C NMR (CDCl3, 75MHz) δ= 160.0 (C=O), 
146.8 (CH-C=C-S), 142.1 (CAr), 140.1 (CH=C-NH), 134.1 (2CHAr), 131.5 (Cl-CAr), 130.8 
(CH-C=C-S), 129.0 (2CHAr), 127.6 (CH=CH-S), 124.7 (CH=CH-S), 101.7 (CH-C-NH). MS 
(EI): m/z (%) = 263 (37Cl M+, 40) 261 (35ClM+, 100), 226 (M+-Cl, 5), 149 (M-C6H5Cl, 13). 
HRMS: m/z calcd for C13H8NOS37Cl (M+) 262.9986, found: 262.9989. m/z calcd for 
C13H8NOS35Cl (M+) 261.0015, found: 261.0022. 
7-Ethyl-5,6-dihydro[1,6]naphthyridin-5-one (8a). From 2-methylnicotinic acid 4 (307 mg, 
2.25 mmol) and propionitrile a (0.16 ml, 2.25 mmol) and lithium diethylamide (from BuLi 
3.2 ml, 1.6 molar, and diethylamine 0.10 ml, 0.96 mmol).Yield: 137 mg (35%); m.p. 197-198oC 
(orange prisms). Recovered starting acid: 15 mg (7%). IR (KBr): νmax= 3162, 3005, 2965, 1671, 
1636, 1590, 1552, 1466, 1323, 1101, 1073, 903, 860, 772 cm-1. 1H NMR (CDCl3, 300MHz): δ= 
11.70 (s, 1H, NH), 8.87 (d, 1H, J= 5.1 Hz, N=CH-CH=CH), 8.62 (d, 1H, J= 8.2 Hz, N=CH-
CH=CH), 7.32 (dd, 1H, J= 8.2 and 5.1 Hz, N=CH-CH=CH), 6.61 (s, 1H, CH=C-NH), 2.74 (q, 
2H, J= 7.5 Hz, CH2-CH3), 1.37 (t, 3H, J= 7.5 Hz, CH3). 13C NMR (CDCl3, 75MHz) δ= 164.9 
(C=O), 155.1 (N-C=C-CO), 154.9 (N=CH-CH=CH), 147.8 (CH=C-NH), 135.6 (N=CH-
CH=CH), 120.8 (N=CH-CH=CH), 119.9 (N-C=C-CO), 105.0 (CH=C-NH), 26.6 (CH2CH3), 12.2 
(CH3). MS (EI): m/z (%) = 174 (M+, 100), 173 (M+-1, 69), 159 (M+-CH3, 17), 146 (M+-CO, 12), 
132 (M+-CON, 11). HRMS: m/z calcd for C10H10N2O (M+) 174.0793, found 174.0794. 
7-Isopropyl-5,6-dihydro[1,6]naphthyridin-5-one (8b). From 2-methylnicotinic acid 4 
(307 mg, 2.25 mmol) and isobutyronitrile b (0.20 ml, 2.25 mmol) and lithium diisopropylamide 
(from BuLi 3.2 ml, 1.6 molar, and diisopropylamine 0.14 ml, 0.96 mmol).Yield: 200 mg (50%); 
m.p. 190-192oC (yellow prisms). Recovered starting acid: 9 mg (5%). IR (KBr): νmax= 3163, 
3014, 2962, 2890, 1673, 1636, 1590, 1383, 1246, 979, 903, 857 cm-1. 1H NMR (CDCl3, 
300MHz): δ= 10.00 (s, 1H, NH), 8.88 (d, 1H, J= 5.1 Hz, N=CH), 8.61 (d, 1H, J= 8.2 Hz, 
N=CH-CH=CH), 7.35 (dd, 1H, J= 8.2 and 5.1 Hz, N=CH-CH=CH), 6.61 (s, 1H, CH=C-NH), 
2.90 [m, 1H, CH(CH3)2], 1.37 [d, 6H, J= 5.9 Hz, CH(CH3)2]. 13C NMR (CDCl3, 75MHz) δ= 
165.0 (C=O), 155.4 (C=C-CO), 155.1 (N=CH-CH=CH), 152.1 (CH=C-NH), 135.9 (N=CH-
CH=CH), 121.0 (N=CH-CH=CH), 120.4 (C=C-CO), 103.8 (CH=C-NH), 32.6 [CH(CH3)2], 21.5 
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(CH3). MS (EI): m/z (%) = 188 (M+, 100), 187 (M+-H, 19), 173 (M-CH3, 99), 160 (M-CO, 12), 
155 (M+-CH3-H2O, 18). HRMS: m/z calcd for C11H12N2O (M+) 188.0950, found 188.0946. 
7-(4-Methylphenyl)-5,6-dihydro[1,6]naphthyridin-5-one (8c). From 2-methylnicotinic acid 4 
(307 mg, 2.25 mmol) and p-methylbenzonitrile c (269 mg, 2.25 mmol) and lithium diethylamide 
(from BuLi 3.2 ml, 1.6 molar, and diethylamine 0.10 ml, 0.96 mmol).Yield: 324 mg (61%); m.p. 
265-267oC (yellow prism). Recovered starting acid: 27 mg (9%). IR (KBr): νmax= 3035, 1646, 
1463, 1429, 1300, 1217, 1098, 1033, 872, 836, 811 cm-1. 1H NMR (CDCl3, 300MHz): δ= 9.38 
(s, 1H, NH), 8.92 (d, 1H, J= 5.1 Hz, N=CH-CH=CH), 8.63 (d, 1H, J= 8.2 Hz, N=CH-CH=CH), 
7.66 (d, 2H, J= 8.2 Hz, 2 CHAr), 7.38 (dd, 1H, J= 8.2 and 5.1 Hz, N=CH-CH=CH), 7.35 (d, 2H, 
J= 8.2 Hz, 2 CHAr), 7.03 (s, 1H, CH=C-NH), 2.43 (s, 1H, CH3). 13C NMR (CDCl3, 75MHz) δ= 
163.9 (C=O), 155.1 (N=CH-CH=CH), 154.9 (C=C-CO), 152.1 (CH=C-NH), 143.4 (CH=C-NH), 
140.5 (CAr-CH3), 135.8 (N=CH-CH=CH), 130.8 (CAr), 130.0 (2 CHAr), 126.2 (2 CHAr), 121.3 
(N=CH-CH=CH), 120.2 (C=C-CO), 105.5 (CH=C-NH), 21.3 (CH3). MS (EI): m/z (%) = 236 
(M+, 100), 221 (M+-CH3, 3), 207 (M+-COH, 5), 180 (M+-C2H2NO, 4), 119 (M+-C8H7N, 3), 91 
(C7H7+, 3). HRMS: m/z calcd for C15H12N2O (M+), 236.0950, found 236.0954. 
7-(4-Chlorophenyl)-5,6-dihydro[1,6]naphthyridin-5-one (8d). From 2-methylnicotinic acid 4 
(307 mg, 2.25 mmol) and p-chlorobenzonitrile d (313 mg, 2.25 mmol) and lithium 
diisopropylamide (from BuLi 3.2 ml, 1.6 molar, and isopropylamine 0.5 ml, 5 mmol).Yield: 
432 mg (75%); m.p. 310-312oC dec. (yellow solid). Recovered starting acid: 24 mg (8%). IR 
(KBr): νmax= 3163, 2964, 1674, 1628, 1589, 1404, 1300, 1261, 1192, 1093, 871, 805, 774 cm-1. 
1H NMR (DMSO, 400MHz): δ= 9.14 (s, 1H, NH), 8.90 (d, 1H, J= 5.1 Hz, N=CH-CH=CH), 
8.49 (d, 1H, J= 8.2 Hz, N=CH-CH=CH), 7.83 (d, 2H, J= 8.2 Hz, 2 CHAr), 7.54 (d, 2H, J= 
8.2 Hz, 2 CHAr), 7.46 (dd, 1H, J= 8.2 and 5.1 Hz, N=CH-CH=CH), 6.90 (s, 1H, CH=C-NH), 
2.43 (s, 1H, CH3). 13C NMR (DMSO, 75MHz) δ= 163.5 (C=O), 155.6 (N=CH-CH=CH), 154.9 
(C=C-CO), 143.6 (CH=C-NH), 135.6 (N=CH-CH=CH), 130.4 (CAr), 129.5 (2 CHAr), 129.45 (2 
CHAr), 128.5 (ClCAr), 122.4 (N=CH-CH=CH), 122.0 (C=C-CO), 105.6 (CH=C-NH). MS (EI): 
m/z (%) = 258 (37ClM+, 34), 256 (35ClM+, 100), 221 (M+-Cl, 7), 193 (M+-CO-Cl, 8), 91 (C7H7+, 
4). HRMS: m/z calcd for C14H9N2O37Cl (M+) 258.0374, found: 258.0381. m/z calcd for 
C14H9N2O35Cl (M+), 256.0403, found: 256.0412. 
7-(2-Pyridinyl)-5,6-dihydro[1,6]naphthyridin-5-one (8e). From 2-methylnicotinic acid 4 
(307 mg, 2.25 mmol) and 2-cyanopyridine e (237 mg, 2.25 mmol) and lithium diisopropylamide 
(from BuLi 3.2 ml, 1.6 molar, and isopropylamine 0.14 ml, 0.96 mmol).Yield: 264 mg (56%). 
IR (KBr): νmax= 3321, 3050-2900, 1680, 1630, 1590, 1531, 1469, 998, 778 cm-1. 1H NMR 
(CDCl3, 500MHz): δ= 9.30 (s, 1H, NH), 8.91 (m, 1H, CH-N-C-C-CONH), 8.65 (m, 1H, CH-N-
C-C-NHCO), 8.55 (m, 1H, NHCO-C-CH), 8.18 (m, 1H, N-CH-CH-CH-CH), 7.95 (m, 1H, N-
CH-CH-CH-CH), 7.81 (m, 1H, N-CH-CH-CH-CH), 7.38 (m, 2H, CH-CH-C-CONH and CH-C-
NH). 13C NMR (MeOD, 75MHz) δ= 162.4 (C=O), 155.1 (CH-N-C-C-CONH), 155.0 (C-C-
CONH), 149.3 (CH-N-C-C-NHCO), 148.0 (C-C-CONH), 139.4 (C-C-NHCO), 137.0 (N-CH-
CH-CH-CH), 136.0 (CH-C-CONH), 125.4 (N-CH-CH-CH-CH), 123.0 (C-CONH), 122.7 (N-
CH-CH-CH-CH), 120.2 (CH-CH-C-CONH), 105.2 (CH-C-NHCO). MS (EI): m/z (%) = 223 
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(M+, 100), 195 (M+-CO, 18), 119 (C8H7O+, 8), 79 (C5H5N+, 12), 78 (C5H4N+, 11). HRMS: m/z 
calcd for C13H9N3O (M+) 223.0746, found: 223.0745. 
2,4,6-Tri(2-pyridyl)-1,3,5-triazine (9). From 3-methyl-2-thiophenecarboxylic acid 3 (326 mg, 
2.25 mmol) and 2-cyanopyridine e (235 mg, 2.25 mmol) and lithium diethylamide (from BuLi 
3.2 ml, 1.6 molar, and diethylamine 0.5 ml, 5 mmol).Yield: 51 mg (46%); m.p. 180-81oC (dec.) 
(yellow prism). Recovered starting acid: 212 mg (65%). IR (KBr): νmax= 3500-2800, 1642, 1582, 
1529, 1368, 1253, 995, 769 cm-1. 1H NMR (CDCl3, 400MHz): δ= 8.96 (ddd, 1H, J=4.8, 2.0, 
1.6 Hz, N-CH), 8.86 (dt, 1H, J=8.0 and 1.2 Hz, N-CH-CH-CH-CH), 7.97 (dt, 1H, J=7.6 and 
2.0 Hz, N-CH-CH-CH-CH), 7.55 (ddd, 1H, J=7.6, 4.8 and 1.6 Hz, N-CH-CH-CH-CH). 13C 
NMR (CDCl3, 75MHz) δ= 161.3 (N-C=N), 150.7 (N-CH), 137.3 (N-CH-CH-CH-CH), 128.9 (C-
N-CH), 126.8 (N-CH-CH-CH-CH), 125.4 (N-CH-CH-CH-CH). MS (EI): m/z (%) = 313 (M++1, 
22), 312 (M+, 100), 208 (M+-C6H4N2, 56), 105 (C6H5N2+, 57), 104 (M+-2C6H4N2, 26), 78 
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